Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostate Adenocarcinoma × Radiosurgery × Clear all

Phase

Phase NA 2 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Brain Neoplasms 20 Carcinoma, Non-Small-Cell Lung 14 Pancreatic Neoplasms 11 Neoplasm Metastasis 10 Prostatic Neoplasms 9 Melanoma 9 Lung Neoplasms 7 Glioblastoma 7 Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Glioma 5 Carcinoma, Hepatocellular 5 Neoplasms 4 Head and Neck Neoplasms 4 Uveal Melanoma 3 Colorectal Neoplasms 3 Carcinoma, Renal Cell 3 Adenocarcinoma 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Oropharyngeal Neoplasms 2 Oligodendroglioma 2 Mouth Neoplasms 2 Liver Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Gliosarcoma 2 Fallopian Tube Neoplasms 2

Interventions

enzalutamide 2 entinostat 1 bicalutamide 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04943536 2026-02-27

BiolenRT

Alessa Therapeutics Inc.

Phase 1 Active not recruiting

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡